Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Oncotarget|June 15, 2018
Lymph microvascularization as a prognostic indicator in neuroblastomaIrene Tadeo, Esther Gamero-Sandemetrio, Ana P Berbegall, et al.
Oncotarget|February 27, 2016
Vascular patterns provide therapeutic targets in aggressive neuroblastic tumorsIrene Tadeo, Gloria Bueno, Ana P Berbegall, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 28, 2020
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell lineAmparo López-Carrasco, Susana Martín-Vañó, Rebeca Burgos-Panadero, et al.
International Journal of Surgical Pathology|March 26, 2019
Extra-Adrenal Adult Neuroblastoma With Aberrant Germ Cell Marker Expression: Maturation After Chemotherapy as an Important Clue to a Challenging DiagnosisCarolina Martinez-Ciarpaglini, Isidro Machado, Akihiko Yoshida, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 2, 2022
[Histological, immunohistochemical and molecular study of a paratesticular dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features]Isidro Machado, Encarnación Martí Ibor, Ana P Berbegall, et al.
Anti-Cancer Drugs|May 31, 2018
9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastomaAndrey V Ugolkov, Gennadiy I Bondarenko, Oleksii Dubrovskyi, et al.
International Journal of Cancer|September 16, 2014
Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumoursNoémie Braekeveldt, Caroline Wigerup, David Gisselsson, et al.
Cancer Letters|March 23, 2016
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumoursNoémie Braekeveldt, Caroline Wigerup, Irene Tadeo, et al.
Cell Reports|September 23, 2020
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in NeuroblastomaJoachim Tetteh Siaw, Niloufar Javanmardi, Jimmy Van den Eynden, et al.
Cancer Research|August 30, 2018
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in NeuroblastomaNoémie Braekeveldt, Kristoffer von Stedingk, Susanne Fransson, et al.
Pageof 3